HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IL-18 deficiency selectively enhances allergen-induced eosinophilia in mice.

AbstractBACKGROUND:
T(H2) cytokines are associated with airway inflammation and hyperreactivity in bronchial asthma, and restoration of the T(H1)/T(H2) imbalance is a potential avenue for novel therapies. IL-18 is a cytokine secreted by activated macrophages, and it shares some of its biologic activities with IL-12, a typical T(H1)-type cytokine. Although IL-18 and IL-12 act on T cells synergistically to induce IFN-gamma production, the contribution of IL-18 T(H1)/T(H2) imbalance and to subsequent asthmatic response has not been elucidated in vivo.
OBJECTIVE:
We studied a model of allergic asthma in IL-18-deficient mice to investigate the modulatory role of IL-18 on induction and maintenance of T(H2) mucosal immunity. We also have investigated the ability of intraperitoneal instilled IL-18 to reduce T(H2) mucosal immunity in IL-18-deficient mice.
METHODS:
IL-18-deficient mice immunized to ovalbumin by means of intraperitoneal injection were challenged 3 times with an aerosol of ovalbumin every second day for 8 days. Recombinant (r)IL-18 was intraperitoneally administered in mice before every first challenge. Mice were analyzed for effects on lung eosinophilia, cytokines, and serum IgE levels.
RESULTS:
In IL-18-deficient mice, levels of eosinophilia and lung damage were significantly higher than in wild-type C57/BL6 litter mates. Intraperitoneal administration of rIL-18 in deficient mice reduced these antigen-induced changes to levels seen in wild-type mice in association with a decrease in IL-4 in bronchoalveolar lavage fluid and lung tissue. However, administration of rIL-18 did not affect the IFN-gamma level and somewhat enhanced the production of IL-5. Notably, reconstitution with rIL-18 increased the numbers of cells staining for Fas ligand, as well as apoptotic cells stained by nick end-labeling in bronchial submucosa infiltrates.
CONCLUSION:
These findings indicate that in vivo IL-18 not only inhibited antigen-specific T(H2) development but also affected apoptosis through Fas-Fas ligand interactions. These data support a role for IL-18 in the complex pathogenesis of allergic inflammation in which IL-18 limited the development of the local inflammatory response to antigen.
AuthorsT Kodama, T Matsuyama, K Kuribayashi, Y Nishioka, M Sugita, S Akira, K Nakanishi, H Okamura
JournalThe Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 105 Issue 1 Pt 1 Pg. 45-53 (Jan 2000) ISSN: 0091-6749 [Print] United States
PMID10629451 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Allergens
  • Cytokines
  • Interleukin-18
  • Recombinant Proteins
  • Immunoglobulin E
Topics
  • Allergens (immunology)
  • Animals
  • Apoptosis (drug effects)
  • Asthma (immunology, physiopathology)
  • Bronchial Hyperreactivity (immunology)
  • Cytokines (metabolism)
  • Eosinophilia (immunology, pathology, physiopathology)
  • Immunoglobulin E (metabolism)
  • Interleukin-18 (deficiency, pharmacology)
  • Lung (drug effects, metabolism, pathology, physiopathology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Recombinant Proteins (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: